Skip to main content
SecondaryClaims
Back to Condition Library

Fibromyalgia Gulf War Illness Presumptive

How Gulf War veterans claim fibromyalgia as a Gulf War illness presumptive for VA disability. Covers eligibility, tender point criteria, rating, evidence requirements, and filing guidance.

Last updated: 2026-04-18

What Is Fibromyalgia as a Gulf War Illness Presumptive?

Fibromyalgia is a chronic musculoskeletal condition characterized by widespread pain, fatigue, sleep disruption, and cognitive difficulties ("fibro fog"). It is one of the three specific medically unexplained chronic multisymptom illnesses (alongside CFS and functional gastrointestinal disorders) recognized as Gulf War illness presumptives under 38 CFR § 3.317.

Veterans who served in the Southwest Asia theater beginning August 2, 1990, who develop fibromyalgia, are entitled to presumptive service connection — without needing to prove a specific causal link between their service and the diagnosis. This is particularly important for fibromyalgia, which by definition lacks a clear organic pathology and is therefore extremely difficult to service-connect through the traditional nexus framework.

The combination of widespread pain, fatigue, and cognitive symptoms in fibromyalgia produces significant functional impairment that is reflected in VA ratings up to 40% for the condition alone — and higher total ratings when depression, anxiety, and sleep disorders are claimed as secondary conditions.

Why the VA Recognizes This Connection

Gulf War illness multisymptom cluster. Fibromyalgia fits squarely within the broader Gulf War illness symptom complex — a pattern of widespread pain, fatigue, cognitive difficulties, headaches, and mood disturbance that has been documented at elevated rates in deployed Gulf War veterans compared to non-deployed controls.

Central sensitization. Research in Gulf War illness and fibromyalgia suggests a common underlying mechanism: central sensitization — a state in which the central nervous system amplifies pain signals, producing widespread pain from stimuli that would not normally be painful. Gulf War-specific exposures (chemical agents, pesticides, PB pills) may contribute to central sensitization development.

Neuroimmune dysregulation. Both fibromyalgia and Gulf War illness share features of dysregulated immune and autonomic nervous system function — elevated inflammatory markers, abnormal HPA axis responses, and altered sympathetic tone — suggesting common pathophysiological mechanisms.

Epidemiological evidence. Studies comparing Gulf War veterans to non-deployed era controls document substantially higher rates of widespread musculoskeletal pain and fibromyalgia-like symptoms in the deployed group.

38 CFR § 3.317 framework. The VA regulatory framework recognizes fibromyalgia as a MUCMI — a condition where the current understanding of Gulf War service exposures is sufficient to presume causation without individual proof.

The VA's Gulf War illness resources provide qualifying service criteria.

Evidence That Wins This Claim

For the presumptive pathway:

  • Proof of qualifying service: DD-214 documenting service in the Southwest Asia theater on or after August 2, 1990.
  • Fibromyalgia diagnosis: A physician's formal diagnosis meeting ACR criteria — either the 2010 criteria (widespread pain index + symptom severity score) or the 1990 tender point criteria.
  • Documentation of 10%+ disability: Clinical records showing that fibromyalgia symptoms substantially reduce activity or require continuous medication.

Supporting documentation:

  • Rheumatology evaluation: A rheumatologist's diagnosis carries strong evidentiary weight for fibromyalgia claims.
  • Tender point examination records: If using 1990 criteria, documentation of the number and location of positive tender points.
  • Widespread Pain Index and symptom severity scores: If using 2010 criteria, documentation of WPI and SS scores from a clinical assessment.
  • Medication records: Medications prescribed specifically for fibromyalgia (duloxetine, pregabalin, milnacipran) support both the diagnosis and the disability rating.
  • Functional impact documentation: Records of activity limitation, workplace accommodations, or disability leave attributable to fibromyalgia.

How the VA Rates Fibromyalgia

Fibromyalgia is rated under Diagnostic Code 5025:

RatingCriteria
40%Widespread musculoskeletal pain and tender points, with or without associated fatigue, sleep disturbance, stiffness, paresthesia, headache, irritable bowel symptoms, depression, anxiety, or Raynaud's-like symptoms, and requiring continuous medication for control
20%With the above symptoms that are episodic, with exacerbations nearly as great as in the 40% rating
10%With symptoms controlled or basically controlled by continuous medication

Why These Claims Get Denied — And How to Prevent It

No formal fibromyalgia diagnosis. Self-reported widespread pain without a physician's diagnosis meeting ACR criteria is insufficient. A rheumatologist's evaluation with formal diagnosis documentation is strongly recommended.

Qualifying service not verified. Ensure DD-214 confirms Southwest Asia theater service on or after August 2, 1990.

10% threshold not met. The presumptive requires at least 10% disability. Clinical documentation of functional impairment or continuous medication requirement establishes this threshold.

Secondary conditions not claimed. Depression, anxiety, and sleep disorders co-occurring with fibromyalgia are separately ratable and significantly increase total compensation when claimed.

CFS not separately claimed. Veterans with both fibromyalgia and CFS should claim both separately.

Related Conditions

Next Steps

For a complete guide to Gulf War illness presumptive claims, see the Gulf War Illness Claims Playbook.


This is educational content, not legal advice. SecondaryClaims.com is not accredited by the VA under 38 CFR § 14.629. For accredited representation, consult a VA-accredited VSO, claims agent, or attorney at https://www.va.gov/ogc/apps/accreditation/.